J&J gets subpoena over sales of bile-duct stents

08/4/2008 | Bloomberg

The U.S. Attorney's Office in Massachusetts has issued a subpoena to Johnson & Johnson asking for information about the sales of its bile-duct stents, according to a U.S. Securities and Exchange Commission filing. A spokeswoman for J&J's Cordis unit said the company is "cooperating and responding to the subpoena" and did not comment further. Other biliary stent companies, including Abbott Laboratories and Boston Scientific, are similarly cooperating with the U.S. Justice Department's investigation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA
Senior Compliance Analyst
ACell, Inc.
Columbia, MD
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ